You are here

          

Key dates

Abstract submission and registration opens - April 5, 2018
Abstract submission deadline
- June 8, 2018
Early registration deadline
- June 19, 2018
Late registration deadline
- October 9, 2018
SIOG 2018 Annual Conference - November 16-18, 2018 (Friday to Sunday!)

Download

SIOG 2018 Save the date flyer.pdf

SIOG 2018 Scientific Programme_dated 16 May 2018.pdf

Join us in Amsterdam for SIOG 2018!

Our SIOG Annual Conference is the leading conference for health professionals involved in the treatment of older cancer patients and provides a unique platform for oncologists, researchers, clinical practitioners, geriatricians, radiologists, psychologists, nutritionists, nurses and other healthcare professionals as well as senior cancer survivor advocates who wish to learn, interact and share results and best practice. It also allows for important improvements in the understanding and the practice of this multidisciplinary approach when treating senior adults with cancer.

Our conference features speakers from among the world’s leading experts in this field and enables participants to:

  • Learn from the experience of peers
  • Showcase their expertise on a global stage
  • Demonstrate their commitment to the multidisciplinary approach to treat cancer in the elderly
  • Network with leaders from across the oncology and geriatric communities

Please note that SIOG is implementing all the necessary measures to be compliant with the EU GDPR (General Data Protection Regulation). Should you wish to withdraw your permission to receive any SIOG related news or to request a copy of your personal data, please contact us at info@siog.org

SIOG 2018 Scientific Programme Committee

Pierre Soubeyran, SIOG Chair, SIOG 2018 Scientific programme committee

Pierre Soubeyran, M.D., Ph.D., is a Medical Oncologist at Institut Bergonié, Comprehensive Cancer Center in Bordeaux, and Professor of Medical Oncology at the University of Bordeaux. He is highly involved in the development of Geriatric Oncology at both the clinical (co-coordinator of the Coordination Unit of Geriatric Oncology of Aquitaine) and research level (President of the French Society of Geriatric Oncology (SoFOG) and Co-coordinator of the French Geriatric Oncology Cooperative Group DIALOG). He is also involved in cancer research as Director of the U1218 INSERM Cancer research unit and Director of the SIRIC, Center for Integrated Cancer Research of Bordeaux, named BRIO (Bordeaux Recherche Intégrée Oncologie) with among its major focus areas development of geriatric oncology with multiple projects in clinical and biological research as well as in epidemiology, public health and humanities and social sciences.

He earned his Medical Degree from the University of Nantes in France and trained in Medical Oncology at the Institut Bergonié and University of Bordeaux. He completed a fellowship at the MD Anderson Cancer Center in Houston and later obtained his Ph.D. at the University of Bordeaux in the field of minimal residual disease in follicular lymphoma. An active researcher, Prof. Pierre Soubeyran’s clinical interests include clinical and biological research on lymphoma and geriatric oncology. He is leading trials focused on these topics as part of the French LYSA lymphoma Research Group and the French Geriatric Oncology Cooperative Group DIALOG. He is a member of ESMO, ASCO, ASH, SoFOG and SIOG. He has authored and co-authored numerous articles, book chapters and monographs on various aspects of cancer treatment. He was granted the Paul Calabresi Award from SIOG in 2012, the BJ Kennedy Award from ASCO in 2016 and the Ehrenpreis geriatrische onkologie für das lebenswerk from DGHO and DGG in Germany in 2017.

 

Stuart Lichtman, Co-Chair, SIOG 2018 Scientific programme committee

Dr. Lichtman is an Attending Physician and Member, Memorial Hospital for Cancer and Allied Diseases, Member, Memorial Sloan-Kettering Cancer Center and Professor of Medicine, Weill Cornell Medical College. He is a member of the 65+ Clinical Geriatrics Program and Gynecologic Oncology Disease Management Team at the Center. He has been on the Board of Directors and Treasurer of SIOG since 2010 and has participated in multiple taskforces (Chemotherapy, as chair, Geriatric Assessment, Renal Dysfunction, Lymphoma, Oral Chemotherapy), US National Representative and Scientific Chair of the 2011 meeting. He has been a participant in the Alliance for Clinical Trials in Oncology (formerly CALGB) as a member of the Pharmacology and Experimental Therapeutics Committee (1990-2008), the Cancer in the Elderly Committee (1995-present).

His work also included the Scientific Advisory Board of the Geriatric Oncology Consortium, the Elderly Taskforce of the Gynecologic Oncology Group, Cancer and Aging Research Group and the NCCN Guidelines Taskforce for the treatment, Evaluation of Older Women with Breast Cancer, Editorial Board of the Journal of Geriatric Oncology, External Advisory Board of the University of Iowa Cancer Center, Governing Board Cancer and the Kidney International Network. He has been a member of ASCO since 1988 and have been an active participant by serving on the Clinical Practice Committee, Scientific Program Committee, Geriatric Oncology Special Interest Group, an invited speaker at Educational Sessions, ASCO University, ASCO Post and a faculty member of the ASCO/AACR Vail Clinical Trials workshop for five sessions on the topic of special populations. He has been a guest editor for a special edition devoted to Geriatric Oncology for the Journal of Clinical Oncology (2007 and 2014). He has published over 100 articles in peer review journals, contributed to nine book chapters and edited three books and have been an invited speaker and many national and international meetings on Geriatric Oncology. In 2014 he received the ASCO BJ Kennedy Award for Scientific Excellence in Geriatric Oncology.

 

Johanna Portielje, Local chair, SIOG 2018 Scientific programme committee

Johanneke Portielje is professor of geriatric oncology at Leiden University Medical Center and the Haga Hospital in The Hague. She is an attending physician and member of the breast cancer team, the gynaecologic oncology team and the geriatric oncology team. She is involved in graduate medical education and head of the medical oncology senior residency program.

Her research interests include geriatric oncology and breast cancer. She is chair of GeriOnNe, the foundation for geriatric oncology in the Netherlands and is the national representative for SIOG. She is on the editorial board of the journal of geriatric oncology.

She received her medical degree at Leiden University and subsequently was  a research fellow at the preclinical research department of Sandoz in Basel. She obtained her board certification in internal medicine at Leiden University and specialized in oncology and defended her thesis at the Daniel den Hoed Clinic / Eramus Medical Center Rotterdam.

 

Matti Aapro, Chair, SIOG Corporate Relations Committee

Matti Aapro is presently Dean of the Multidisciplinary Oncology Institute, Genolier, Switzerland. He coordinates the SPCC programme of the European School of Oncology (ESO) and serves the International Society for Geriatric Oncology (SIOG) as Executive Board member.  He has been member of the Board of EORTC and ESMO. He is past-President of the Multinational Association for Supportive Care in Cancer (MASCC), is now on its Board of Directors for 2014-2016, and is appointed Co-Chair of MASCC’s Antiemetic Study Group, effective June 2014.

He is Editor-in-Chief of Critical Reviews in Oncology/Hematology, associate editor for the geriatric section of the Oncologist and founding editor of the Journal of Geriatric Oncology (JGO). He is past Associate Editor for Annals of Oncology. He directs the qualityoflife.elsevierresource.com website. He has authored more than 250 publications and his major interests are new drug development, breast cancer, supportive care, and cancer in the elderly. Dr Aapro is Doctor Honoris Causa of the University of Tampere  (2013) and has received the 2010 Acta Oncologica Award and the 2012 ASCO B.J. Kennedy prize.

 

Marije Hamaker, SIOG 2018 scientific programme committee

Marije Hamaker has been working as a clinical geriatrician working at the Diakonessenhuis in Utrecht, the Netherlands since 2010. In 2012, she defended her PhD thesis on “Decision making in geriatric oncology”. She has remained active in geriatric oncology research, focusing on treatment decisions and patient-centered outcome measures in various cancer types, and additionally has set up a project regarding geriatric nephrology in 2014.

She is an active member of the Dutch Geriatric Oncology Foundation, the Elderly Task Force of the EORTC as well as a member of SIOG and the Dutch Geriatrics Society.

 

 

SIOG 2018 Track leaders

Track 1: Solid tumours in the elderly and basic science
Camille Chakiba (FR)
Romain Corre (FR)
Nienke de Glas (NL)
Grégoire Desolneux (FR)
Havaleh Gagne (US)
Karis Kin-Fong Cheng (SG)
Malcolm Reed (GB)
Armin Shahrokni (US)
Enrique Soto Perez de Celis (MX)
Frederiek Van den Bos (NL)
Kathelijn Versteeg (NL)

Track 2: Hematologic malignancies and basic science
Raul Cordoba (SP)
Melissa Loh (US)
Simon Mooijaart (NL)
Nina Rosa Neuendorff (DE)
Petra Stolz-Baskett (NZ)
Sonja Zweegman (NL)

Track 3: Supportive and palliative
Shabbir Alibhai (CA)
Rupert Bartsch (AT)
Matthieu Frasca (FR)
Domenico La Carpia (IT)
Ginah Nightingale (US)
Mackenzi Pergolotti (US)
Carla Ripamonti (IT)
Cornelia van Zuylen (NL)
Grant Williams (US)

Track 4: Modern diagnostics and therapeutic areas
Laure de Decker (FR)
Fabio Gomes (PT/GB)
Mandy Kiderlen (NL)
Gerrit Jan Liefers (NL)
Anita O'Donovan (IE)
Martine Puts (CA)
Ishwaria Subbiah (US)

Track 5: Geriatric assessment, nursing/allied health and patient care
Katarzyna Broczek (PL)
Frank Cornélis (BE)
William Dale (US)
Kristen Haase (CA)
Cindy Kenis (BE)
Beatriz Korc Grodzicki (US)
Cecilia Lund (DK)
Shane O'Hanlon (GB)
Carolien Smorenburg (NL)
Melisa Wong (US)

Overall scientific rationale of the SIOG 2018 Scientific programme

This year’s SIOG Annual Conference shall evolve around the theme “Geriatric oncology – becoming mainstream cancer care” with educational sessions on varied topics for surgeons, radiation oncologists, medical oncologists, geriatricians, nurses and allied health professionals.

Although we accumulate data and evidence, implementation of geriatric oncology care remains too much limited. While management and expertise improves in referral hospitals and in trained teams, many older patients do not benefit from our improvements. Consequently, besides our usual research objectives such as refinement of the process to identify vulnerable elders and improvement of treatment strategy, we should as well develop new approaches to limit inequalities of access to our innovations. To achieve this goal, we have to develop collaborations with all disciplines and develop new tools to reach all patients. We have also to work with health authorities.

The scientific sessions will emphasize the optimal ways clinicians can use the information to better assess patients and help make treatment decisions to maximize benefit. The conference presentations for educational sessions could be divided into purely didactic talks and audience interaction sessions presenting cases. Examples could be:

  • Using geriatric predictive models, i.e. CARG, e-prognosis and tumour specific models, decision making for chemotherapy
  • The use of biomarkers,  i.e. mutations to make therapeutic decisions
  • Immunotherapy for melanoma, i.e. single agent vs. combinations; in BRAF mutations: mutation directed treatment vs. Immunotherapy
  • Using components of geriatric assessment to aid in decision making, i.e. history of falls, dependence in a component of IADL, polypharmacy

Scientific programme at-a-glance

 

Download

Download the latest version of our SIOG 2018 preliminary scientific programme (as of May 16, 2018).
NB: Please note this programme is subject to change.

 

SIOG 2018 endorsements

 

                                  

 

Under the auspices of

 

SIOG 2018: Scientific programme tracks

The programme is built around the following scientific tracks:
Track 1: Solid tumours and basic science
Track 2: Hematologic malignancies and basic science
Track 3: Supportive care and palliative care
Track 4: Modern diagnostics and therapeutic areas
Track 5: Geriatric assessment, nursing/allied health and patient care

To adhere to the theme of the conference, each track leader shall emphasize the role of validated models into presentations and discussions.

Track 1: Solid tumours and basic science

Data are accumulating about new drugs, especially targeted therapies, which are practice changing. Yet older patients, particularly when vulnerable or frail, are excluded from these studies. New and expensive biological tests are needed which may be denied the elderly. Furthermore, data about efficacy and toxicity are limited although these new medications will be implemented in older patients. This track needs to explore these areas including cost-utility studies.

  • Strategies to implement prospective trials for the evaluation of new innovative therapies in older patients including vulnerable and frail people; novel trial designs; modify standard eligibilities
  • Evaluation of the validity of pharmacokinetics and pharmacogenomics in older patients; their importance in light of advances in immunotherapy
  • Evaluation of benefit / risk ratio of targeted therapies in older patients with cancer including pharmaco-epidemiologic studies
  • Evaluation of cost-effectiveness of precision medicine in older patients with cancer
  • Possible to include some aspects of surgery, i.e. preoperative evaluation; post op complications, i.e. delirium;
  • Radiation oncology; toxicity of combined modality therapy; maybe part of survivorship—long term toxicity of RT particularly pelvic RT

1.1 Breast
1.2 Prostate, bladder, kidney, genitourinary cancers
1.3 Lung
1.4 Colorectal & GI cancers
1.5 Gynaecological cancers
1.6 Melanomas & other skin cancers
1.7 Head & neck
1.8 Sarcoma
1.9 Basic science & translational research
1.10 Other

 

Track 2: Hematologic malignancies and basic science

Most hematologic malignancies concern old patients. This is particularly true in myeloma, chronic lymphoproliferative disorders and MDS/leukaemia. Better understanding of the biology of these diseases currently lead to many new therapies which may change the aim of treatment from palliative to curative in some cases. The impact on clinical practice will be important in younger patients but this progress may be denied to the older ones.

  • Implementation of geriatric management guidelines in myeloma and CLL
  • Chemotherapy versus targeted treatment in indolent lymphomas
  • Is cure the ultimate goal in all large cell lymphomas whatever fitness?
  • New therapies for myelodysplastic disease and acute leukaemia in the elderly
  • BMT/stem cell transplantation

2.1 CLL
2.2 CML
2.3 MDS, AML
2.4 Lymphoma
2.5 Myeloma
2.6 Basic science & translational research
2.7 Other

 

Track 3: Supportive care and palliative care

This is a broad area which covers comorbidities, chronic toxicities and the issues of survivorship. Early implementation of palliative care is a major objective to be carried out. Supportive care to survivors should be developed.

  • Early implementation of palliative care
  • Advanced care planning in the sense of goal setting for systemic therapies (i.e. chemotherapy, targeted therapy) in the palliative setting
  • Specificities of palliative care in the elderly
  • Providing supportive care to survivors
  • Anxiety, sleep disorders and depression in older patients
  • Management of chronic toxicities and comorbidity; the role of the oncologist vs. PCP;
  • Survivorship prescriptions
  • Avoidance of chronic toxicity
  • Geriatric psychiatry
  • Polypharmacy-compliance, adherence, deprescribing, drug interactions

3.1 Sarcopenia, cachexia and nutrition
3.2 Bone marrow toxicity (neutropenia, infection, myelosuppression & anaemia)
3.3 Polypharmacy
3.4 Palliative care
3.5 Antiemetics
3.6 Bone health
3.7 Cognitive impairment & delirium management
3.8 Neuro toxicity
3.9 Mobility, ADLs and falls
3.10 Fatigue
3.11 Psycho-oncology
3.12 Pain
3.13 Other

 

Track 4: Modern diagnostics and therapeutic areas

Introduction of precision medicine modifies clinical practice and patient/physician relationships so that our model of care is changing. Digital tools enlarge our possibilities to communicate with patients as often as necessary. Clinical trial designs need to adapt to these new types of studies while incorporated geriatric principles.

  • Telemedicine and digital devices
  • Human and social science approach of precision medicine and innovation in the context of the elderly
  • Implementation of hypofractionated radiotherapy in the elderly
  • How to reduce inequalities of access to innovative treatment
  • Collaboration with Health authorities to implement geriatric oncology for all
  • Interventional radiology in older patients, i.e. ablative procedures, palliative procedures
  • IT for patient reported outcomes

4.1 Diagnostics & genomic tools
4.2 Surgery
4.3 Radiotherapy
4.4 Chemotherapy
4.5 Immunotherapies
4.6 Biosimilars
4.7 Developmental therapeutics
4.8 Clinical trials for elderly cancer patients
4.9 Basic science
4.10 Other

 

Track 5: Geriatric assessment, nursing/allied health and patient care

Geriatric assessment of older patients by the geriatric team cannot be proposed to all patients in every hospital. Consequently, we should develop selection strategies to identify patients who may benefit from geriatric team management. Moreover, the place of the geriatrician and team in the oncology decision making should be optimized to become available to each patient who may need it. Development of self-assessment may be part of the solution and the current development of patient reported outcome may be highly beneficial to the oldest as well as patient education.

  • Implementation of consensus selection process for all patients
  • Improvement of endpoints for clinical trials and routine practice; clinical trial design
  • Use of patient reported outcomes to improve management of patients
  • Standardization of geriatric intervention;
  • Implementation of geriatricians in multidisciplinary meetings
  • Development of patient education
  • Standard geriatric dataset for clinical trials
  • Nursing education in geriatric oncology

5.1 Geriatric assessment
5.2 Nursing
5.3 Patient care
5.4 Communication
5.5 Ethical, cultural and spiritual aspects
5.6 Economics issues
5.7 Healthcare organization/models of care
5.8 Distress and psycho-social issues
5.9 Patient advocacy
5.10 Other

This year's conference theme is: “Geriatric oncology – becoming mainstream cancer care" and the SIOG 2018 Scientific Programme Committee is looking forward to receiving numerous abstract submissions from the geriatric oncology community with their latest findings to be presented at our SIOG 2018 Annual Conference.

Why submit an abstract?

  • Present your research and share your knowledge with your peers
  • SIOG awards: get recognized for your outstanding work
  • Networking opportunities with professionals from all around the world
  • Visibility all year long with the publication of your abstract in the Journal of Geriatric Oncology
  • Media visibility: unique opportunity to be interviewed by ecancer


The abstract submission is NOW CLOSED.

All abstract submissions are blind peer-reviewed for scientific content, logical presentation, and current interest of the topic by the SIOG 2018 Scientific Programme Committee and track leaders. The outcome of the review will be communicated by e-mail to all abstract submitters at the end of July 2018.

 

Download

Abstract submission Guidelines

 

Abstract publication

Accepted abstracts are published online as a supplement of the Journal of Geriatric Oncology (JGO), impact factor of 2.852; referenced in PubMed.

 

Abstract session types 

Oral abstract presentations
Each session is composed of four to five topic-related abstracts. The two chairpersons are chosen for their expertise in the topics presented and will conduct the session.

Poster presentations
Abstract selected for poster presentation will be displayed on poster panels located in the poster area for the entire duration of the conference.

 

Questions?

For further assistance, please contact our team at MCI Geneva at SIOG.abs@mci-group.com

 

SIOG 2018 awards

SIOG 2018 Young Investigator Award

The aim of the SIOG Young Investigator Award is to promote research in the field of geriatric oncology and to recognise the outstanding contribution of these investigators in understanding, preventing and treating cancer in older patients. This is the first award to be established in geriatric oncology at an international level.

Eligibility criteria
To be eligible for the award candidates must

  • Be a SIOG member
  • Born after 1978
  • Be young / new in the field of geriatric oncology and / or working as a trainee in any discipline that is involved with treatment of older cancer patients (e.g. surgery, radiotherapy, medical oncology, urology, pulmonology, haematology, etcetera) and / or PhD student, postdoctoral fellow or researcher
  • Have their abstract accepted for oral presentation at the SIOG 2018 Annual Conference in Amsterdam.

IMPORTANT: The abstract submitted for the SIOG Young Investigator Award must NOT have been published, nor submitted for publication for another meeting or publication.

How to apply?

The abstract submission is NOW CLOSED.

  1. Applicants will be notified by the end of July 2018 if they are a finalist for the SIOG 2018 Young Investigator Award.
  2. Finalists will present their work within one of the abstract sessions during the SIOG 2018 Annual Conference in Amsterdam, Netherlands. Based on the presentation, members of the Scientific Programme Committee (judging panel) will then select the winner who is to be announced at the Presidential session on November 16, 2018.

Evaluation criteria
Selected for the outstanding quality of their work, three Young Investigators will be competing for this prestigious SIOG Award presenting their original research in front of the conference delegates and members of the Scientific Programme Committee.

Applications will be judged on:

  • The scientific merit of the abstract
  • The quality and originality of the manuscript
  • The oral abstract presentation

IMPORTANT: As the SIOG Young Investigator Award is judged in part on the presentation of the finalist’s work at the scientific session taking place at the Annual Conference, the finalist must be the presenter of his/her submission and no alternates or proxy will be allowed. 

Prize
The winner of SIOG Young Investigator Award receives an award of EUR 1,000 with a free registration for the SIOG 2019 conference and a diploma. The monetary prize is meant to stimulate further research work. The prize will be awarded during the Presidential session of the SIOG 2018 Annual Conference in Amsterdam, Netherlands. The 2 other finalists will each receive EUR 500 along with a free registration for the SIOG 2019 conference.

Each finalist will be announced in the Scientific Programme of the SIOG 2018 Annual Conference as a SIOG 2018 Young Investigator Award finalist and the abstract will be published in a supplement to Journal of Geriatric Oncology.

The award winner will also benefit from a unique opportunity to be interviewed by ecancer, the international leading oncology channel news.

IMPORTANT: When submitting an abstract for the SIOG Young Investigator Award, the first prize winner commits to submitting the full manuscript pertaining to the presented research for consideration for publication in the Journal of Geriatric Oncology –SIOG’s official journal.

 

SIOG 2018 Young SIOG Research Prize

The aim of the Young SIOG Research Session is to provide a unique opportunity to young SIOG members to present their new research to a panel of experts in order to receive feedback to their proposal.

Eligibility criteria

  • Be a SIOG member
  • Born after 1978
  • Be young / new in the field of geriatric oncology and / or working as a trainee in any discipline that is involved with treatment of older cancer patients (e.g. surgery, radiotherapy, medical oncology, urology, pulmonology, haematology,...) and / or PhD student, postdoctoral fellow or researcher
  • Submit a proposal for a new study that has not started yet

How to apply

The abstract submission is NOW CLOSED.

  1. Applicants will be notified by the end of July 2018 if they are selected.  
  2. 4 finalists will present their research project during the Young SIOG Research Session held during the SIOG 2018 Annual Conference in Amsterdam, Netherlands.

Prize
The best proposal will be awarded with an official SIOG certificate and a free registration for the SIOG 2019 Annual Conference.

 

SIOG 2018 Nursing and Allied Health Investigator Award

The SIOG Nursing and Allied Health Working Group is committed to professional growth of new investigators in geriatric oncology nursing and allied professions. The SIOG Nursing / Allied Health Investigator Award aims to promote research in the field of nursing in geriatric oncology and to recognize the outstanding contribution of these investigators in understanding and caring for cancer in older patients. This is the first award to be established in geriatric oncology nursing and allied professions at an International level.

Eligibility criteria
To be eligible for the award candidates must

  • Be a SIOG member
  • Be the principle investigator for an original research project in the area of nursing or another allied health profession.
  • Have their abstract accepted for oral presentation at the SIOG 2018 Annual Conference in Amsterdam.

IMPORTANT: The abstract submitted for the SIOG Nursing and Allied Health Investigator Award must not have been published, nor submitted for publication for another meeting or publication.

How to apply?

The abstract submission is NOW CLOSED.

  1. Applicants will be notified by the end of July 2018 if they are a finalist for the SIOG Nursing and Allied Health Investigator Award.
  2. Finalists will present their work within one of the abstract sessions during the SIOG 2018 Annual Conference in Amsterdam, Netherlands. Based on the presentation, members of the Scientific Programme Committee (judging panel) will then select the winner who is to be announced at the Presidential session on November 16, 2018.

Evaluation criteria
Selected for the outstanding quality of their work, three Nursing and Allied Health investigators will be competing for this prestigious SIOG Award presenting their original research in front of the conference delegates and members of the Scientific Programme Committee.

Applications will be judged on:

  • The scientific merit of the abstract
  • The quality and originality of the manuscript
  • The oral abstract presentation

IMPORTANT: As the SIOG Nursing and Allied Health Investigator Award is judged in part on the presentation of the finalist’s work at the scientific session taking place at the Annual Conference, the finalist must be the presenter of his/her submission and no alternates or proxy will be allowed. 

Prize
The winner of SIOG Nursing and Allied Health Investigator Award receives an award of EUR 1,000 with a free registration for the SIOG 2019 conference and a diploma. The monetary prize is meant to stimulate further research work. The prize will be awarded during the Presidential session of the SIOG 2018 Annual Conference in Amsterdam, Netherlands. The 2 other finalists will each receive EUR 500 along with a free registration for the SIOG 2019 conference.

Each finalist will be announced in the Scientific Programme of the SIOG 2018 Annual Conference as a SIOG 2018 Nursing and Allied Health Investigator Award finalist and the abstract will be published in a supplement to Journal of Geriatric Oncology.

The award winner will also benefit from a unique opportunity to be interviewed by ecancer, the international leading oncology channel news.

IMPORTANT: When submitting an abstract for the SIOG Nursing and Allied Health Investigator Award, the first prize winner commits to submitting the full manuscript pertaining to the presented research for consideration for publication in the Journal of Geriatric Oncology – SIOG’s official journal.

Registration procedure

All participants must be registered to attend the SIOG Annual Conference.

For Conference registration and hotel reservation all participants must complete an online registration form. The SIOG 2018 Annual Conference requires the full data for each individual participant, including updated postal address and e-mail address. Incomplete registrations cannot be processed.

Confirmation of the registration will be sent only when the corresponding payment is received in full. While registering online, you will be asked to create a user-account or use the one already created for past events, this user-account will enable you to come back to your data to update them if needed.

For further information regarding the registration, please contact:

SIOG 2018 c/o MCI Suisse SA
9, Rue du Pré-Bouvier, 1242 Satigny, Geneva, Switzerland
Phone: +41 (0)22 33 99 722
Email: siogreghot@mci-group.com

MCI Group, on behalf of the congress, may collect your personal data to process your request and respond to you. For more information: Privacy Statement

SIOG 2018 Registration fees

Save on the registration fees by registering before June 19, 2018!

Registration typeEarly fee
(before June 19)
Late fee
(before Oct. 09)
Onsite fee
(as of Oct. 09)
SIOG Member€ 500€ 625€ 780
Non-member€ 730€ 910€ 1’140
SIOG Member
Trainee/Nurse/Patient advocate
€ 295€ 370€ 460
Non-member
Trainee/Nurse/Patient advocate
€ 565€ 705€ 880

 

Delegates' registration fee includes

  • Access to all scientific sessions
  • Access to the scientific posters and scientific display area
  • Conference material
  • Poster welcome reception
  • Access to online abstract book (searchable pdf format)
  • Access to Conference proceedings after the Conference
  • Morning and afternoon coffee break
  • WIFI connection
  • VAT

Optional

  • Daily lunch package at € 35.- per day incl. VAT - Lunch buffet with choice of salads, warm dishes, desserts and soft drinks
  • SIOG 2018 Networking dinner on the evening of Saturday, November 15, 2018 at € 70.- incl. VAT, which will include a boat transfer & aperitif to the dinner venue via the canals.

Early registrations will be accepted until Tuesday, June 19, 2018, midnight CET. Should your registration remain unpaid until Wednesday, 20 June 2018; your early registration fee will be upgraded to the Pre-registration fee. As of Wednesday, June 20, 2018, Pre-registration fees apply for every new registration.

Should your registration remain unpaid past Tuesday, October 9, 2018: your Pre-registration fee will be upgraded to the late registration fee.

From Wednesday, October 10, 2018, the late registration fee applies for every new registration.

 

Accommodation

The headquarter hotel of the SIOG 2018 Annual Conference is the Novotel Amsterdam City, where SIOG Governance and faculty will be staying.

If you wish to book your accommodation at this hotel where special rates have been negotiated, please contact MCI at siogreghot@mci-group.com

 

General information

Conference documents & badges
Conference documents should be collected on-site at the registration desk. Please retain the confirmation letter and bring it with you to the conference, as it will facilitate your registration process. Name badges must be worn visibly at all times during the conference and in the exhibition area.

Conference venue
RAI Amsterdam
Convention Centre
Europaplein 2-22
1078 GZ Amsterdam
The Netherlands
Website: https://www.rai.nl/en/

Accompanying person
Kindly note that no programme/registration is foreseen for accompanying persons at the SIOG 2018 Annual Conference. Children will not be allowed at the conference.

Registration and accommodation terms and conditions
Please view the individual registration and accommodation terms and conditions here.

Insurance and liability
The conference organizers accept no liability for any injury or damage (including personal injury or for any loss, cost or damage to property belonging to conference participants) arising out of or in connection with the conference, including but not limited to during any activities. It is recommended that participants, as well as companies, arrange their own personal health, accident, travel, property loss/damage insurance or any other necessary insurance. MCI Suisse SA acts as agent and cannot be held responsible for any loss, cost, injury or damage to any person or property whatever the cause may be.

Key dates

Abstract submission and registration opens - April 5, 2018
Abstract submission deadline
- June 8, 2018
Early registration deadline
- June 19, 2018
Late registration deadline
- October 9, 2018
SIOG 2018 Annual Conference - November 16-18, 2018 (Friday to Sunday!)


Conference venue

RAI Amsterdam, Entrance E - Forum Centre,
Europaplein 2-22, 1078 GZ Amsterdam, The Netherlands
http://www.rai.nl/en/

 

 

Headquarter hotel

Novotel Amsterdam City Hotel
Europaboulevard 10, 1083 AD  Amsterdam, The Netherlands
https://www.accorhotels.com/gb/hotel-0515-novotel-amsterdam-city/index.shtml

For further information, please contact:
Conference secretariat 
MCI Suisse SA, SIOG 2018
9, Rue du Pré-Bouvier, 1242 Satigny, Switzerland
Tel: +41 22 33 99 722 
E-mail: siogreghot@mci-group.com


General information

Amsterdam: An iconic international destination - accessible and connected

Amsterdam is a historic city with a futuristic outlook that meshes business growth with sustainable initiatives. There’s a lot to experience for locals and visitors, too: Amsterdam is packed with cultural, historical and architectural delights – from museums and attractions to restaurants, cafés, shopping and nightlife. The city’s cultural scene is bustling, ensuring visitors can have both a memorable meeting and great experiences after business hours. And transport is straight-forward and convenient, whether it’s by taxitraintrammetrobusferry, bike or on foot, so journeys are short, pleasant and enlightening for guests from the Netherlands or beyond.

Amsterdam’s connectivity is one of the major reasons why it’s the perfect location to host your meeting. Amsterdam Airport Schiphol is one of Europe’s four major hubs, operating to more than 300 direct destinations, with exceptional public transport connections to the city – 20 minutes or less to the city centre – and a taxi fleet that is 100% electric.

Plan you trip

The Netherlands – country of the bicycle!.
“Ride as much or as little, as long or as short as you feel. But ride” – Eddy Merckx
A resource article about the health benefits of cycling https://www.bikemunk.com/health-benefits-cycling/

 

 

Promotional Video

Industry partners

It is our pleasure to invite you to join us for the 2018 SIOG Annual Conference which will take place in Amsterdam, Netherlands from November 16-18, 2018.

The majority of your cancer patients is above 65 years old. In order to provide high-quality, evidence-based care for this growing group of individuals, it is essential to meld the principles of Geriatrics and Oncology. The need to address these patients in order to optimize their cancer treatment is the goal of SIOG who fosters the development of health professionals in the field of geriatric oncology. The SIOG Annual Conference provides the platform to present the latest evidence based research in the care of older adults with cancer in order to provide an educational opportunity for all clinicians and allied health professional in oncology.

The programme of the conference will include multidisciplinary sessions on solid tumours, haematological malignancies, new therapies, geriatric assessment, supportive care needs and an educational forum dedicated to nurses. The SIOG Annual Conference also includes special sessions in collaboration with industry to present the latest therapeutic data and their application to the older adults.

SIOG is also dedicated to the development of allied health professionals and junior faculty with the attribution of the SIOG Nursing & Allied Health and the SIOG Young Investigator awards.

Amsterdam is a historic city with a futuristic outlook that meshes business growth with sustainable initiatives. There’s a lot to experience for locals and visitors, too: Amsterdam is packed with cultural, historical and architectural delights – from museums and attractions to restaurants, cafés, shopping and nightlife. The city’s cultural scene is bustling, ensuring you can have both a memorable meeting and great experiences after conference hours. And transport is straight-forward and convenient, whether it’s by taxitraintrammetrobusferry, bike or on foot, so journeys are short, pleasant and enlightening for attendees from the Netherlands or beyond.

So join us in Amsterdam for the 18th SIOG Annual Conference. We look forward to seeing you there!

Download

SIOG 2018 Education & Partnership brochure
SIOG 2018 Scientific display booking form
SIOG 2018 Industry sponsored satellite session booking form
SIOG 2018 Corporate Sponsorship booking form

For further information, please contact our SIOG Head Office
1-5 Route des Morillons, P.O. Box 2100
1211 Geneva - Switzerland
Tel: +41 22 552 3305
E-mail: events@siog.org

Contact us

SIOG Head Office (For questions concerning SIOG 2018 scientific programme and industry partnerships)
1-5 route des Morillons, PO Box 2100, 1211 Geneva 2, Switzerland 
Tel: +41 22 552 33 05 
Fax: +41 22 552 33 06 
E-mail: events@siog.org
www.siog.org

Conference secretariat 
MCI Suisse SA, SIOG 2018
9, Rue du Pré-Bouvier, 1242 Satigny, Switzerland

Registration and accommodation (groups and individual) 
MCI Suisse SA 
Tel: +41 22 33 99 722 
Fax: +41 22 33 99 631 
E-mail: siogreghot@mci-group.com

Abstract handling 
MCI Suisse SA 
Tel: +41 22 33 99 614 
Fax: +41 22 33 99 601 
E-mail: siog.abs@mci-group.com

MCI Group, on behalf of the congress, may collect your personal data to process your request and respond to you. For more information: Privacy Statement

Please note that SIOG is implementing all the necessary measures to be compliant with the EU GDPR (General Data Protection Regulation). Should you wish to withdraw your permission to receive any SIOG related news or to request a copy of your personal data, please contact us at info@siog.org

Please read the PCO’s Privacy policy related to the congress here.